Showing results (11-20 of 5,223) with videos related to
Sort By:
Pageof 523
Current Neuropharmacology|January 17, 2025
Myelin Repair as a Novel Mechanism for Ketamine's Sustained Antidepressant EffectsSen Wang, Chaoli Huang, Mengyu Wang, et al.Translational Psychiatry|December 19, 2017
Possible role of the gut microbiota-brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress modelChun Yang, Youge Qu, Yuko Fujita, et al.Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|April 17, 2008
[Minocycline as a therapeutic drug for methamphetamine use disorders]Kenji HashimotoAdvances in Clinical Chemistry|February 27, 2018
Metabolomics of Major Depressive Disorder and Bipolar Disorder: Overview and Future PerspectiveKenji HashimotoCurrent Pharmaceutical Design|June 6, 2015
Targeting of α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational BiomarkerKenji HashimotoBrain Research Reviews|June 2, 2009
Emerging role of glutamate in the pathophysiology of major depressive disorderKenji HashimotoNihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|July 30, 2010
[Role of sigma-1 receptors in neural plasticity and in antipsychotic action]Kenji HashimotoEuropean Archives of Psychiatry and Clinical Neuroscience|January 6, 2021
Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptorKenji HashimotoCurrent Psychiatry Reports|July 7, 2019
Recent Advances in the Early Intervention in Schizophrenia: Future Direction from Preclinical FindingsKenji HashimotoMolecular Psychiatry|October 16, 2023
Emerging role of the host microbiome in neuropsychiatric disorders: overview and future directionsKenji HashimotoPageof 523